MedPath
FDA Approval

Next Choice

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
October 29, 2012
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Levonorgestrel(0.75 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

H.J. Harkins Company, Inc.

147681894

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

H.J. Harkins Company, Inc.

H.J. Harkins Company, Inc.

H.J. Harkins Company, Inc.

147681894

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Next Choice

Product Details

NDC Product Code
52959-450
Application Number
ANDA078665
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
October 29, 2012
Code: 5W7SIA7YZWClass: ACTIBQuantity: 0.75 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8Class: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath